Cyrille Coustal

Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX

Jérôme Hadjadj, Yann Nguyen, Dalila Mouloudj et al. · Annals of the Rheumatic Diseases · 2024 · 64 citations

Medicine, Molecular Genetics, Pharmacology +10

Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series

Cyrille Coustal, Juliette Vanoverschelde, Xavier Quantin et al. · Journal for ImmunoTherapy of Cancer · 2023 · 28 citations · Full text

Life Sciences, Immunology, Oncology +17

Time to use the right classification to predict the severity of checkpoint inhibitor‐induced liver injury, as assessed for causality using the updated <scp>RUCAM</scp>

Lina Hountondji, Stéphanie Faure, Pascale Palassin et al. · Alimentary Pharmacology & Therapeutics · 2024 · 14 citations · Full text

Medicine, Immunology, Oncology +17

Clinical, Radiologic, and Immunologic Features of Patients With CTLA4 Deficiency With Neurologic Involvement

Cyrille Coustal, Radjiv Goulabchand, Pierre Labauge et al. · Neurology · 2023 · 12 citations · Full text

Life Sciences, Immunology, Neurology +13

Neurological manifestations in patients with VEXAS syndrome

Charlotte Bert-Marcaz, Étienne Fortanier, Antoine Briantais et al. · Journal of Neurology · 2025 · 12 citations

Medicine, Neurology, Neuroscience +6